ERICH3
gene geneOn this page
Also known as DKFZp547I048RP11-653A5.1
Summary
ERICH3 (glutamate rich 3, HGNC:25346) is a protein-coding gene on chromosome 1p31.1, encoding Glutamate-rich protein 3 (Q5RHP9). Component of the primary cilium that controls cilium formation and length.
Involved in cilium assembly. Located in cytoplasm and non-motile cilium.
Source: NCBI Gene 127254 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 241 total
- MANE Select transcript:
NM_001002912
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25346 |
| Approved symbol | ERICH3 |
| Name | glutamate rich 3 |
| Location | 1p31.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp547I048, RP11-653A5.1 |
| Ensembl gene | ENSG00000178965 |
| Ensembl biotype | protein_coding |
| OMIM | 620866 |
| Entrez | 127254 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 2 protein_coding, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000326665, ENST00000420661, ENST00000433746, ENST00000479666, ENST00000614534
RefSeq mRNA: 1 — MANE Select: NM_001002912
NM_001002912
CCDS: CCDS30755
Canonical transcript exons
ENST00000326665 — 15 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001366041 | 74606601 | 74606902 |
| ENSE00001367225 | 74612623 | 74612809 |
| ENSE00001403696 | 74649222 | 74649315 |
| ENSE00001405342 | 74643027 | 74643098 |
| ENSE00001407414 | 74673497 | 74673792 |
| ENSE00001408337 | 74636280 | 74636438 |
| ENSE00001428105 | 74641331 | 74641459 |
| ENSE00001429867 | 74646667 | 74646792 |
| ENSE00001453838 | 74599695 | 74599931 |
| ENSE00001730999 | 74576895 | 74576936 |
| ENSE00001949164 | 74568123 | 74570439 |
| ENSE00002246327 | 74589631 | 74590080 |
| ENSE00003433707 | 74631713 | 74631928 |
| ENSE00003590709 | 74620734 | 74620914 |
| ENSE00003689734 | 74571099 | 74573491 |
Expression profiles
Bgee: expression breadth ubiquitous, 172 present calls, max score 99.32.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.0359 / max 57.4145, expressed in 132 samples.
FANTOM5 promoters (11 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 12858 | 0.3473 | 92 |
| 12857 | 0.3436 | 93 |
| 12860 | 0.0948 | 59 |
| 12859 | 0.0779 | 55 |
| 12848 | 0.0495 | 26 |
| 12852 | 0.0418 | 26 |
| 12851 | 0.0276 | 16 |
| 12856 | 0.0257 | 4 |
| 12853 | 0.0171 | 5 |
| 12854 | 0.0066 | 3 |
Top tissues by expression
245 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bronchial epithelial cell | CL:0002328 | 99.32 | gold quality |
| bronchus | UBERON:0002185 | 98.58 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 96.45 | gold quality |
| right uterine tube | UBERON:0001302 | 95.88 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 95.82 | gold quality |
| oviduct epithelium | UBERON:0004804 | 93.80 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 92.33 | gold quality |
| left testis | UBERON:0004533 | 91.24 | gold quality |
| right testis | UBERON:0004534 | 90.66 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 90.40 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 90.10 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 89.57 | gold quality |
| postcentral gyrus | UBERON:0002581 | 88.86 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 88.71 | gold quality |
| testis | UBERON:0000473 | 88.67 | gold quality |
| entorhinal cortex | UBERON:0002728 | 87.70 | gold quality |
| primary visual cortex | UBERON:0002436 | 87.56 | gold quality |
| parietal lobe | UBERON:0001872 | 87.19 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 86.53 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 84.93 | gold quality |
| occipital lobe | UBERON:0002021 | 84.74 | gold quality |
| prefrontal cortex | UBERON:0000451 | 84.69 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 83.97 | gold quality |
| fallopian tube | UBERON:0003889 | 83.88 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.79 | gold quality |
| nucleus accumbens | UBERON:0001882 | 83.79 | gold quality |
| frontal cortex | UBERON:0001870 | 83.76 | gold quality |
| cerebral cortex | UBERON:0000956 | 83.39 | gold quality |
| neocortex | UBERON:0001950 | 83.30 | gold quality |
| sperm | CL:0000019 | 83.07 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-114 | yes | 62.21 |
| E-GEOD-130148 | yes | 13.10 |
| E-ANND-3 | yes | 11.17 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
127 targeting ERICH3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-6856-5P | 100.00 | 65.47 | 1298 |
| HSA-MIR-574-5P | 100.00 | 66.01 | 989 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-8075 | 99.97 | 67.20 | 962 |
| HSA-MIR-7152-3P | 99.97 | 67.47 | 849 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-8082 | 99.95 | 67.27 | 1170 |
Literature-anchored findings (GeneRIF, showing 2)
- Enterovirus 71 VP1 promotes 5-HT release by upregulating the expression of ERICH3 and methyltransferase ZC3H13. (PMID:35660571)
- The ERICH3 rs11580409 polymorphism is associated with 6-month antidepressant response in depressed patients. (PMID:35878676)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | erich3 | ENSDARG00000069262 |
| mus_musculus | Erich3 | ENSMUSG00000078161 |
| rattus_norvegicus | Erich3 | ENSRNOG00000009533 |
Protein
Protein identifiers
Glutamate-rich protein 3 — Q5RHP9 (reviewed: Q5RHP9)
All UniProt accessions (2): Q5RHP9, R4GMY5
UniProt curated annotations — full annotation on UniProt →
Function. Component of the primary cilium that controls cilium formation and length. May function within retrograde intraflagellar transport (IFT)-associated pathways to remove signaling proteins from primary cilia. Also involved in neuronal vesicle biogenesis and neurotransmitter vesicular function.
Subunit / interactions. Interacts with CLTC/clathrin heavy chain 1, AP2A2/AP-2 complex subunit alpha-2, and PIK3C2A/phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha.
Subcellular location. Cell projection. Cilium. Cytoplasm. Cytoskeleton. Cilium axoneme.
Tissue specificity. Expressed in dopaminergic and serotoninergic neurons.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5RHP9-1 | 1 | yes |
| Q5RHP9-2 | 2 | |
| Q5RHP9-3 | 3 |
RefSeq proteins (1): NP_001002912* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027962 | ERICH3 | Family |
| IPR048257 | DUF4590 | Domain |
Pfam: PF15257
UniProt features (42 total): compositionally biased region 19, region of interest 9, sequence variant 6, splice variant 5, sequence conflict 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5RHP9-F1 | 44.25 | 0.09 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 82 (showing top):
GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN, GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_CILIUM_ORGANIZATION, GOBP_ORGANELLE_ASSEMBLY, GOBP_CELL_PROJECTION_ORGANIZATION, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOCC_CYTOPLASMIC_REGION, GOCC_CILIUM, DODD_NASOPHARYNGEAL_CARCINOMA_DN, GOCC_NON_MOTILE_CILIUM, SNAPC4_TARGET_GENES, SRSF9_TARGET_GENES, GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP, TERF1_TARGET_GENES
GO Biological Process (1): cilium assembly (GO:0060271)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (5): cytoplasm (GO:0005737), cilium (GO:0005929), axoneme (GO:0005930), non-motile cilium (GO:0097730), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| axoneme assembly | 1 |
| intraciliary transport involved in cilium assembly | 1 |
| cilium organization | 1 |
| protein localization to cilium | 1 |
| organelle assembly | 1 |
| trans-Golgi to periciliary membrane compartment transport | 1 |
| plasma membrane bounded cell projection assembly | 1 |
| ciliary transition zone assembly | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cytoskeleton | 1 |
| microtubule | 1 |
| ciliary plasm | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
1076 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ERICH3 | TSPAN5 | P62079 | 738 |
| ERICH3 | KLHL26 | Q53HC5 | 543 |
| ERICH3 | CIMAP1D | Q3SX64 | 541 |
| ERICH3 | TAFA2 | Q8N3H0 | 472 |
| ERICH3 | PLCD4 | Q9BRC7 | 456 |
| ERICH3 | KLHL32 | Q96NJ5 | 422 |
| ERICH3 | QPCT | Q16769 | 416 |
| ERICH3 | PLIN4 | Q96Q06 | 412 |
| ERICH3 | SAXO2 | Q658L1 | 409 |
| ERICH3 | CFAP210 | Q0VFZ6 | 407 |
| ERICH3 | TEKT1 | Q969V4 | 407 |
| ERICH3 | AGXT | P21549 | 396 |
| ERICH3 | CFAP77 | Q6ZQR2 | 392 |
| ERICH3 | IQSEC3 | Q9UPP2 | 385 |
| ERICH3 | CCDC17 | Q96LX7 | 384 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ERICH3 | HNRNPM | psi-mi:“MI:0915”(physical association) | 0.400 |
| ERICH3 | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| Tuba3a | CCHCR1 | psi-mi:“MI:0914”(association) | 0.350 |
| Bach1 | SYNM | psi-mi:“MI:0914”(association) | 0.350 |
| METTL14 | HMGB1P1 | psi-mi:“MI:0914”(association) | 0.350 |
| P | psi-mi:“MI:0914”(association) | 0.350 | |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| ERICH3 | MDM2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (9): ERICH3 (Affinity Capture-MS), ERICH3 (Affinity Capture-MS), ERICH3 (Affinity Capture-MS), ERICH3 (Proximity Label-MS), ERICH3 (Proximity Label-MS), ERICH3 (Proximity Label-MS), ERICH3 (Cross-Linking-MS (XL-MS)), ERICH3 (Cross-Linking-MS (XL-MS)), ERICH3 (Affinity Capture-MS)
ESM2 similar proteins: A0JM80, A6H8Y1, A7MBJ2, D3ZF42, E9Q6J5, F4I700, F4J3S1, F4KCE9, F6QRE9, O04251, O82345, P23497, P46100, P48785, P48786, Q04996, Q05B65, Q0WTB8, Q13342, Q15361, Q32MZ4, Q3UZ39, Q3ZBR9, Q4QSC8, Q571C7, Q5H9K5, Q5RHP9, Q61687, Q66HF9, Q7YQM3, Q7YQM4, Q7Z5L2, Q8BJM3, Q8C4A5, Q8C9B9, Q8GZ87, Q8H991, Q8IW19, Q92576, Q940Y3
Diamond homologs: F6QRE9, Q5RHP9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
241 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 215 |
| Likely benign | 17 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2688 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:74589701:A:AC | donor_gain | 1.0000 |
| 1:74589702:C:CC | donor_gain | 1.0000 |
| 1:74589702:CT:C | donor_gain | 1.0000 |
| 1:74589707:AT:A | donor_gain | 1.0000 |
| 1:74599709:T:TA | donor_gain | 1.0000 |
| 1:74599928:TACT:T | acceptor_gain | 1.0000 |
| 1:74599930:CT:C | acceptor_gain | 1.0000 |
| 1:74599932:C:CC | acceptor_gain | 1.0000 |
| 1:74620912:ATCC:A | acceptor_loss | 1.0000 |
| 1:74620913:TC:T | acceptor_gain | 1.0000 |
| 1:74620913:TCC:T | acceptor_loss | 1.0000 |
| 1:74620914:CC:C | acceptor_gain | 1.0000 |
| 1:74620915:C:A | acceptor_loss | 1.0000 |
| 1:74641325:ACT:A | donor_loss | 1.0000 |
| 1:74641327:TCA:T | donor_loss | 1.0000 |
| 1:74641328:CA:C | donor_loss | 1.0000 |
| 1:74641329:A:AC | donor_gain | 1.0000 |
| 1:74641329:ACC:A | donor_loss | 1.0000 |
| 1:74641330:C:A | donor_loss | 1.0000 |
| 1:74641330:C:CC | donor_gain | 1.0000 |
| 1:74641330:CCA:C | donor_gain | 1.0000 |
| 1:74641457:TCCC:T | acceptor_loss | 1.0000 |
| 1:74641459:CCTA:C | acceptor_loss | 1.0000 |
| 1:74641461:T:A | acceptor_loss | 1.0000 |
| 1:74643021:CCTTA:C | donor_loss | 1.0000 |
| 1:74643022:CTTA:C | donor_loss | 1.0000 |
| 1:74643023:TTACC:T | donor_loss | 1.0000 |
| 1:74643024:TACC:T | donor_loss | 1.0000 |
| 1:74643025:A:T | donor_loss | 1.0000 |
| 1:74643026:C:CA | donor_loss | 1.0000 |
AlphaMissense
10051 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:74606901:A:G | C397R | 0.999 |
| 1:74612628:G:C | C394W | 0.999 |
| 1:74612630:A:G | C394R | 0.999 |
| 1:74612712:A:C | C366W | 0.999 |
| 1:74612713:C:T | C366Y | 0.999 |
| 1:74612714:A:G | C366R | 0.999 |
| 1:74612717:A:G | C365R | 0.999 |
| 1:74612761:A:G | L350P | 0.999 |
| 1:74612763:A:C | S349R | 0.999 |
| 1:74612763:A:T | S349R | 0.999 |
| 1:74612765:T:G | S349R | 0.999 |
| 1:74612797:A:G | F338S | 0.999 |
| 1:74612803:A:G | F336S | 0.999 |
| 1:74606899:G:C | C397W | 0.998 |
| 1:74606900:C:G | C397S | 0.998 |
| 1:74606901:A:T | C397S | 0.998 |
| 1:74612629:C:T | C394Y | 0.998 |
| 1:74612661:A:C | F383L | 0.998 |
| 1:74612661:A:T | F383L | 0.998 |
| 1:74612662:A:G | F383S | 0.998 |
| 1:74612663:A:G | F383L | 0.998 |
| 1:74612713:C:A | C366F | 0.998 |
| 1:74612713:C:G | C366S | 0.998 |
| 1:74612714:A:T | C366S | 0.998 |
| 1:74612715:A:C | C365W | 0.998 |
| 1:74612716:C:T | C365Y | 0.998 |
| 1:74612721:G:C | S363R | 0.998 |
| 1:74612721:G:T | S363R | 0.998 |
| 1:74612723:T:G | S363R | 0.998 |
| 1:74612772:G:C | F346L | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000035053 (1:74673823 G>A), RS1000234692 (1:74651912 C>A,T), RS1000244483 (1:74651538 C>T), RS1000339832 (1:74652234 T>C), RS1000381648 (1:74663093 T>C), RS1000387142 (1:74652596 T>C), RS1000397762 (1:74646280 C>A,T), RS1000411208 (1:74574317 T>A,C), RS1000433128 (1:74663629 A>G), RS1000461631 (1:74614021 A>G), RS1000462744 (1:74659275 C>A), RS1000469873 (1:74591180 C>T), RS1000472537 (1:74667797 G>C), RS1000488170 (1:74574104 C>T), RS1000519384 (1:74618662 G>A,C)
Disease associations
OMIM: gene MIM:620866 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004862_35 | Itch intensity from mosquito bite adjusted by bite size | 5.000000e-07 |
| GCST005950_6 | Body mass index x sex x age interaction (4df test) | 1.000000e-15 |
| GCST005951_197 | Body mass index | 4.000000e-13 |
| GCST005953_11 | Body mass index (age <50) | 3.000000e-15 |
| GCST005954_3 | Body mass index x age interaction | 3.000000e-06 |
| GCST007327_185 | Smoking status (ever vs never smokers) | 6.000000e-12 |
| GCST010396_66 | Gut microbiota (bacterial taxa, hurdle binary method) | 8.000000e-06 |
EFO canonical traits (7, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008377 | mosquito bite reaction itch intensity measurement |
| EFO:0008378 | mosquito bite reaction size measurement |
| EFO:0004340 | body mass index |
| EFO:0008007 | age at assessment |
| EFO:0008343 | sex interaction measurement |
| EFO:0004318 | smoking behavior |
| EFO:0007874 | gut microbiome measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB clinical annotations
2 annotations.
| Variant | Type | Level | Drugs | Phenotypes |
|---|---|---|---|---|
| rs11580409 | Efficacy | 3 | antidepressants | Depressive Disorder |
| rs696692 | Efficacy | 3 | citalopram;escitalopram | Depressive Disorder |
PharmGKB variants
2 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs696692 | ERICH3 | 3 | 0.00 | 1 | citalopram;escitalopram |
| rs11580409 | ERICH3 | 3 | 6.00 | 1 | antidepressants |
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases expression, affects cotreatment, increases methylation, decreases expression | 3 |
| Valproic Acid | affects expression, decreases methylation | 2 |
| 6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine | increases expression | 1 |
| decabromobiphenyl ether | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| tetrabromobisphenol A | decreases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | decreases expression | 1 |
| pentabrominated diphenyl ether 100 | decreases expression | 1 |
| hexabrominated diphenyl ether 153 | decreases expression | 1 |
| Fulvestrant | increases methylation, affects cotreatment | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Carbamazepine | affects expression | 1 |
| Demecolcine | decreases expression | 1 |
| Estradiol | increases expression | 1 |
| Ethyl Methanesulfonate | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Lipopolysaccharides | affects response to substance, increases expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Vincristine | decreases expression | 1 |
| Zearalenone | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.